Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population

Journal of Neurology

Volumn 253, Issue 2, 2006, Pages 208-213

  Marrosu, Maria Giovanna ^a   Cocco, Eleonora ^a   Costa, Gianna ^a   Murru, Maria Rita ^a   Mancosu, Cristina ^a   Murru, Raffaele ^a   Lai, Marina ^a   Sardu, Claudia ^b   Contu, Paolo ^b  

^a Binaghi Hospital   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Course; Genetics; HLA; MHC; Multiple sclerosis

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA DQB1 ANTIGEN; HLA DR ANTIGEN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; COURSE EVALUATION; DISEASE COURSE; FEMALE; GENE INTERACTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC EPIDEMIOLOGY; GENETIC PREDISPOSITION; GENETIC RISK; HAPLOTYPE; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE; TELOMERE;

ADOLESCENT; ADULT; AGED; ALLELES; CHILD; CHROMOSOMES; CONFIDENCE INTERVALS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA ANTIGENS; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; ITALY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIVARIATE ANALYSIS; ODDS RATIO;

EID: 32844466626     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-005-0957-y     Document Type: Article

References (39)

1. Barcellos LF, Oksenberg JR, Green AJ, et al. (2002) Genetic basis for clinical expression in multiple sclerosis. Brain 125:150-158
2. Barcellos LF, Oksenberg JR, Begovich AB, et al. (2003) HLA-DR2 effect on susceptibility to multiple sclerosis and influence on disease course. Am J Hum Genet 72:710-716
3. Bruck W, Lucchinetti C, Lassmann H (2002) The pathology of primary progressive multiple sclerosis. Mult Scler 8:93-97
4. Coraddu F, Lai M, Mancosu C, et al. (2003) A genome-wide screen for linkage disequilibrium in Sardinian multiple sclerosis. J Neuroimmunol 143:120-123
5. De la Concha EG, Arroyo R, Crusius JB, et al. (1997) Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele-2 in susceptibility to relapsing/remitting multiple sclerosis. J Neuroimmunol 80:172-178
6. Ebers GC, Sadovnick AD, Risch NJ (1995) A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 377:150-151
7. Ebers GC, Kukay K, Bulman DE, et al. (2001) A full genome search in multiple sclerosis. Neurogenetics 3:145-151
8. Filippi M, Iannucci G, Tortorella C, et al. (1999) Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology 52:588-594
9. Fogdell-Hahn A, Ligers A, Gronning M, Hillert J, Olerup O (2000) Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 55:140-148
10. Granieri E, Casetta I, Govoni V, et al. (2000) The increasing incidence and prevalence of MS in a Sardinian province. Neurology 55:842-848
11. Haines JL, Ter-Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H, et al. (1996) A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Nat Genet 13:469-471
12. Harbo HF, Lie BA, Sawcer S, Celius EG, et al. (2004) Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens 63:237-247
13. Hensiek AE, Sawcer SJ, Feakes R, et al. (2002) HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry 72:184-187
14. Hensiek AE, Roxburgh R, Smilie B, et al. (2003) Updated results of the United Kingdom linkage-based genome screen in multiple sclerosis. J Neuroimmunol 143:25-30
15. Kuokkanen S, Gschwend M, Rioux JD, et al.(1997) Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 61:1379-1387
16. Lampis R, Morelli L, Congia M, et al. (2000) The inter-regional distribution of HLA class II haplotypes indicates the suitability of the Sardinian population for case-control association studies in complex diseases. Hum Mol Genet 9:2959-2965
17. Lampis R, Morelli L, De Virgiliis S, Congia M, Cucca F (2000) The distribution of HLA class II haplotypes reveals that the Sardinian population is genetically differentiated from the other Caucasian populations. Tissue Antigens 56:515-521
18. Lublin FD, Reingold SC (1996) National Multiple Sclerosis. Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 46:907-911
19. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707-717
20. Marrosu MG, Murru MR, Costa G, Murru R, Muntoni F, Cucca F (1998) DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet 7:1235-1237
21. Marrosu MG, Murru R, Murru MR, et al. (2001) Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet 10:2907-2916
22. Mastermann T, Ligers A, Olsson T, Andersson M, Olerup O, Hillert J (2000) HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 48:211-219
23. McDonald WI, Compston A, Edan G, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121-127
24. McDonnell GV, Hawkins SA (2002) Primary progressive multiple sclerosis: increasing clarity but many unanswered questions. J Neurol Sci 199:1-15
25. Mustafa M, Vingsbo C, Olsson T, Issazadeh S, Ljungdahl A, Holmdahl R (1994) Protective influences on Experimental Autoimmune Encephalomyelitis by MHC class I and class II alleles. J Immunol 153:3337-3344
26. Revesz T, Kidd D, Thompson AJ, Barnard RO, McDonald WI (1994) A comparison of pathology of primary and secondary progressive multiple sclerosis. Brain 117:759-765
27. Schlesselman J (1982) Case-Control Studies. Oxford University Press, pp 227-269
28. nd edition, pp 243-269
29. Stevenson VL, Miller DH, Rovaris M, et al. (1999) Primary and transitional progressive MS: a clinical and MRI cross-sectional study. Neurology 52:839-845
30. 1H-MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS. Mult Scler 6:148-155
31. The Transatlantic Multiple Sclerosis Genetics Cooperative (2001) A meta-analysis of genomic screens in multiple sclerosis. Mult Scler 7:3-11
32. Thompson AJ, Kermode AG, Wicks D, et al. (1991) Major differences in the dynamics of primary and secondary progressive multiple sclerosis. Ann Neurol 29:53-62
33. Thompson AJ, Montalban X, Barkhof F, et al. (2001) Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol 47:831-835
34. Thomson G (1995) Mapping disease genes: family based association studies. Am J Hum Genet 57:487-498
35. Von Büdingen HC, Hauser SL, Fuhrmann A, Nabavi CB, Lee JI, Genain CP (2002) Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination. PNAS 99:8207-8212
36. Weinshenker BG, Santrach P, Bissonet AS, et al. (1998) Major histocompatibility complex class II alleles and the course and outcome of MSA population-based study. Neurology 51:742-747
37. Weissert R, Wallstrom E, Storch MK, et al. (1998) MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest 102:1265-1273
38. Yamasaki K, Horiuchi I, Minohara M, et al. (1999) HLA-DPB1*0501- associated opticospinal multiple sclerosis: clinical, neuroimaging and immunogenetic studies. Brain 122:1689-1696
39. Yu M, Kinkel P, Weinstock-Guttman B, Cook DJ, Tuohy VK (1998) HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosis. Hum Immunol 59:15-24